This resolution designates July 28, 2026, as "World Hepatitis Day" to draw critical attention to the severe global and national impact of hepatitis B and C. These viruses are the world's leading causes of primary liver cancer, affecting millions worldwide and in the United States, despite the availability of effective vaccines, treatments, and a cure for hepatitis C. The resolution highlights that progress towards eliminating viral hepatitis as a public health threat has stalled, with a significant portion of infected individuals unaware of their condition and facing barriers to care. The House of Representatives supports broad access to hepatitis B and C vaccination and treatments , and calls for increased awareness regarding the risks and consequences of undiagnosed infections. It urges a robust governmental and public health response to protect the approximately 5.9 million people in the United States affected by these conditions. Furthermore, the resolution specifically calls upon the Centers for Disease Control and Prevention (CDC) to collaborate with State and local health departments to develop strategies aimed at increasing adult hepatitis B vaccination rates and hepatitis C treatment to levels necessary for eliminating new infections.
Recognizing July 28, 2017, as "World Hepatitis Day".
Submitted in House
Referred to the House Committee on Energy and Commerce.
Recognizing July 28, 2026, as "World Hepatitis Day".
USA119th CongressHRES-1458| House
| Updated: 7/23/2026
This resolution designates July 28, 2026, as "World Hepatitis Day" to draw critical attention to the severe global and national impact of hepatitis B and C. These viruses are the world's leading causes of primary liver cancer, affecting millions worldwide and in the United States, despite the availability of effective vaccines, treatments, and a cure for hepatitis C. The resolution highlights that progress towards eliminating viral hepatitis as a public health threat has stalled, with a significant portion of infected individuals unaware of their condition and facing barriers to care. The House of Representatives supports broad access to hepatitis B and C vaccination and treatments , and calls for increased awareness regarding the risks and consequences of undiagnosed infections. It urges a robust governmental and public health response to protect the approximately 5.9 million people in the United States affected by these conditions. Furthermore, the resolution specifically calls upon the Centers for Disease Control and Prevention (CDC) to collaborate with State and local health departments to develop strategies aimed at increasing adult hepatitis B vaccination rates and hepatitis C treatment to levels necessary for eliminating new infections.